Cisen Pharmaceutical Co Ltd (603367) — Cash Flow-to-Debt Ratio
Cisen Pharmaceutical Co Ltd (603367) has a Cash Flow-to-Debt Ratio of 0.22x as of September 2025, meaning its operating cash flow of CN¥311.93 Million could theoretically repay 0% of its total liabilities (CN¥1.43 Billion) in one year. See 603367 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cisen Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Cisen Pharmaceutical Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see Cisen Pharmaceutical Co Ltd (603367) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Cisen Pharmaceutical Co Ltd (2011–2025)
Year-by-year debt coverage analysis for Cisen Pharmaceutical Co Ltd. Check 603367 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | CN¥466.37 Million | CN¥1.37 Billion | ▼ -6.3% |
| 2024 | 0.36x | CN¥570.85 Million | CN¥1.57 Billion | ▲ +26.9% |
| 2023 | 0.29x | CN¥451.24 Million | CN¥1.57 Billion | ▲ +62.2% |
| 2022 | 0.18x | CN¥258.35 Million | CN¥1.46 Billion | ▼ -0.9% |
| 2021 | 0.18x | CN¥233.60 Million | CN¥1.31 Billion | ▼ -43.5% |
| 2020 | 0.32x | CN¥431.01 Million | CN¥1.36 Billion | ▲ +67.4% |
| 2019 | 0.19x | CN¥181.26 Million | CN¥959.97 Million | ▼ -49.2% |
| 2018 | 0.37x | CN¥406.68 Million | CN¥1.09 Billion | ▼ -13.9% |
| 2017 | 0.43x | CN¥439.61 Million | CN¥1.02 Billion | ▲ +45.3% |
| 2016 | 0.30x | CN¥291.97 Million | CN¥982.26 Million | ▲ +4.4% |
| 2015 | 0.28x | CN¥266.24 Million | CN¥935.33 Million | ▲ +719.1% |
| 2014 | 0.03x | CN¥27.54 Million | CN¥792.44 Million | ▼ -72.8% |
| 2013 | 0.13x | CN¥81.26 Million | CN¥636.48 Million | ▲ +81.4% |
| 2012 | 0.07x | CN¥33.09 Million | CN¥470.06 Million | ▼ -78.8% |
| 2011 | 0.33x | CN¥76.28 Million | CN¥230.02 Million | — |